Page 164 - Reuters%20/undefined

Colgate-Palmolive sees weaker annual sales growth on demand slowdown

The company's net sales in Latin America, a major revenue contributing region, fell 7.2 per cent and dropped 1 per cent in North America. On an adjusted basis, its profit of 91 cents per share

Phillips 66 Q4 loss softened by renewable fuels as refining margins fall

On an adjusted basis, the company reported a loss of 15 cents per share in the quarter, compared with the analysts' average estimate of 23 cents loss per share, according to data compiled by LSEG

US prices increases in December amid accelerating consumer spending

The accompanying policy statement did not include the reference to inflation having made progress toward the Fed's 2% target. No rate cut is expected before June

MedPlus Health Q3 results: PAT up at Rs 45.8 cr on strong OTC drug demand

MedPlus continued to benefit from strong sales of products under its private label brands in both the pharmaceuticals and consumer wellness categories

Banks loan growth drops for 6th month in Dec as tighter lending curbs weigh

The data showed that banks' credit increased by 12.4 per cent year-on-year last month, slower than the 15.6 per cent rise in December 2023

OpenAI cites US roots to avoid Indian courts, but lawyers say case holds

Six other lawyers, and submissions of two court-appointed experts in the OpenAI lawsuit, Arul George Scaria and Adarsh Ramanujan, said Indian judges can hear the matter

Fiscal deficit for April-Dec at 56.7% of full-year target, shows data

Net tax receipts for the first nine months of the current financial year were at Rs 18.43 trillion

UPL Q3 results: Net profit at Rs 828 cr on higher agrochemical deman

Revenue from operations rose 10 per cent to Rs 10,907 crore

IndusInd Bank Q3 results: PAT drops 39% to Rs 1,401 cr as provisions jump

The bank's provisions and contingencies, or funds set aside to cover loan losses, jumped 87 per cent to Rs 1,744 crore

Marico Q3 results: PAT rises 4% to Rs 399 crore, revenue jumps 15%

Marico's expenses rose 17.7 per cent to Rs 2,318 crore ($267.54 million) during the third quarter ended December 31

Sun Pharma Q3 results: Net profit up 15% at Rs 2,905 cr on strong sales

Sales in India, Sun Pharma's largest revenue-generating region, rose 14 per cent to Rs 4,300 crore, or about 31 per cent of total sales

RBI injects $5.1 billion liquidity through oversubscribed FX swap auction

The RBI accepted 28 bids, totaling $5.1 billion, in the auction and the premium cut-off was set at 96.81 paisa, slightly below the prevailing market level before the auction results were announced

NSE Nifty likely to see a relief rally in Feb, signals derivatives data

The Nifty has tumbled 11.3 per cent over the last four monthly derivatives series, each of which spans between the last Thursdays of a month, with the most recent one ending on Jan. 30

Bank of Baroda aims to double balance sheet in 5 years: CEO Debadatta Chand

Meanwhile, deposit growth should accelerate to 13% in 2025-26 from an expected 9%-11% this year, with a focus on low-cost current and savings inflows, the CEO said

Confident of US demand despite Trump's concerning policy: Waaree CEO

Waaree expects most of its 5.4 GW solar cell manufacturing capacity in the western state of Gujarat to be operational by March-April this year. The company has about 13.3 GW of capacity module

Gold prices hit record high as Trump tariff concerns drive demand

Gold is considered a safe investment during geopolitical turmoil and thrives in a low interest rate environment

Jubilant Pharmova Q3 result: Profit rises 51% to Rs 101 cr on strong demand

Revenue rose 9 per cent to Rs 1,814 crore, lifted by the radiopharma segment's nearly 12 per cent growth this quarter

Nestle India Q3 results: Profit rises over 6% to Rs 696 cr, revenue up 4%

For Nestle India, home to Nescafe instant coffee and KitKat chocolate brands, revenue increased nearly 4 per cent to Rs 4,780 crore

Economic Survey likely to project 6.3-6.8% GDP growth for next fiscal year

The Survey 2024-25, authored by Chief Economic Advisor V Anantha Nageshwaran and his team, will be tabled in Parliament this afternoon

Trump is getting the demanded lower interest rates from everyone but Fed

Inflation is nearly contained, but the Fed sees enough uncertainty and risk on the horizon that it has moved to the sidelines, at least for now